IP Library Patent Application 17231761
Patent Application
App. No. 17/231,761

FORMULATION BASED ON VITAMIN E OR AN ESTER THEREOF FOR TREATING BACTERIAL AND FUNGAL BIOFILMS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/231,761
Abstract

Formulations for topical use based on vitamin E or an ester thereof for use in removing, reducing or inhibiting a bacterial and/or fungal biofilm are disclosed. The ester of vitamin E is an ester with a carboxylic acid of formula R—COOH, in which R is an alkyl radical having from 1 to 19 carbon atoms, or an alkenyl or alkynyl having from 2 to 19 carbon atoms.

Claims (10)

1 . A method for reducing a bacterial or fungal biofilm, comprising topically applying a formulation consisting of an ester of vitamin E to said bacterial or fungal biofilm.

2 . The method according to claim 1 , wherein said ester of vitamin E is an ester with a carboxylic acid of formula R—COOH, in which R is an alkyl radical having from 1 to 19 carbon atoms, or an alkenyl or alkynyl having from 2 to 19 carbon atoms.

3 . The method according to claim 2 , wherein said ester is alpha-tocopheryl acetate, n-propionate or linoleate.

4 . The method according to claim 3 , wherein said ester is alpha-tocopheryl acetate.

5 . The method according to claim 1 , wherein said formulation consists of vitamin E acetate.

6 . A method for reducing a bacterial or fungal biofilm, comprising topically applying a formulation comprising in weight percentages on the total weight of the formulation, 20 to 70% of vitamin E acetate and 20 to 70% of a volatile silicone to said bacterial or fungal biofilm.

7 . The method according to claim 6 , wherein said volatile silicone is selected from the group consisting of pentamer cyclomethicone, tetramer cyclomethicone, hexamer cyclomethicone, hexamethyldisiloxane, low viscosity dimethicone and mixtures thereof.

8 . The method according to claim 7 , wherein said formulation further comprises 7 to 13% of hydrogenated castor oil by weight of the total weight of the formulation.

9 . The method according to claim 8 , wherein said formulation further comprises 7 to 15% by weight of the total weight of the formulation of an oily component selected from the group consisting of vegetable oils, esters of fatty acids selected from the group consisting of octyl palmitate, isopropyl myristate and ethyl oleate and mixtures thereof.

10 . The method according to claim 9 , wherein said formulation further comprises 2 to 3% of dimethiconol by weight of the total weight of the formulation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2022
From: BIO.LO.GA. S.R.L.
To: HULKA S.R.L.
Reel/Frame 059364/0206 →